Orally available antiviral drug candidate Molnupiravir has the potential to prevent hospitalization if it is given to mild or moderate patients.
Source: Jerusalem Post
Full Article: Israeli research shows US drug can stop progress of COVID-19
Orally available antiviral drug candidate Molnupiravir has the potential to prevent hospitalization if it is given to mild or moderate patients.
Source: Jerusalem Post
Full Article: Israeli research shows US drug can stop progress of COVID-19